Chromosomal and gene amplification in diffuse large B-cell lymphoma

Blood

Volumn 92, Issue 1, 1998, Pages 234-240

  Rao, Pulivarthi H ^a   Houldsworth, Jane ^a   Dyomina, Katerina ^a   Parsa, Nasser Z ^a   Cigudosa, Juan C ^a   Louie, Diane C ^a   Popplewell, Leslie ^a   Offit, Kenneth ^a   Jhanwar, Suresh C ^a   Chaganti, R S K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; GENE AMPLIFICATION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRIDIZATION; LARGE CELL LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 18744421982     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.1.234.413k22_234_240     Document Type: Article

References (46)

1. Armitage JO: Treatment of non-Hodgkin's lymphoma. New Engl J Med 328:1023, 1993
2. Coffier B, Gisselbrecht C, Vose JM, Tilly H, Herbrecht R, Bosly A, Armitage JO: Prognostic factors in aggressive malignant lymphomas: Description and validation of a prognostic index that could identify patients requiring a more intensive therapy. J Clin Oncol 9:211, 1991
3. Dalla-Favera R, Ye BH, Lo Coco F, Gaidano G, Lista F, Knowels DM, Louie DC, Offit K, Chaganti RSK: Identification of genetic lesions associated with diffuse large cell lymphoma. Ann Oncol 5:s55, 1994
4. Schwab M, Amier LC: Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosom Cancer 1:81, 1990
5. Ben-Yehuda D, Houldsworth J, Parsa NZ, Chaganti RSK: Gene amplification in non-Hodgkin's lymphoma. Br J Haematol 86:792, 1994
6. Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K, Chaganti RSK: REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 87:25, 1996
7. Monni O, Joensuu H, Franssila K, Knuutila S: DNA copy number changes in diffuse large B-cell lymphoma-comparative genomic hybridization study. Blood 87:5269, 1996
8. Harris NL, Jaffe EL, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowels DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Pins MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361, 1994
9. Offit K, Wong G, Filippa DA, Tao Y, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 77:1508, 1991
10. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosom Cancer 3:189, 1991
11. Mikraki V, Ladanyi M, Chaganti RSK: Structural alterations in the 5' region of BCL2 gene in follicular lymphomas with BCL2-MBR and SCL2-MCR rearrangements. Genes Chromosom Cancer 3:117, 1991
12. Ladanyi M, Offit K, Jhanwar SC, Filippa DA, Chaganti RSK: MYC rearrangement and translocations involving band 8q24 in diffuse large cell lymphomas. Blood 77:1957, 1991
13. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science 258:593, 1992
14. White E: Life, death, and the pursuit of apoptosis. Genes Dev 10:1, 1996
15. Pearson-White S, Deacon D, Crittenden R, Brady G, Iscove N, Quesenberry PJ: The ski/sno protooncogene family in hematopoietic development. Blood 86:2146, 1995
16. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141, 1994
17. Ayer DE, Eisenman RN: c-myc protooncogene, in Bertino JR (ed): Encyclopedia of Cancer. New York, NY, Academic, 1997, p 419
18. Berns EMJJ, Klijn JGM, van Putten WLJ, van Staveren IL, Portengen H, Foekens JA: c-myc amplification is a better prognostic factor than Her-2/neu amplification in primary breast cancer. Cancer Res 52:1107, 1992
19. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of Her-2/neu protooncogene in human breast and ovarian cancer. Science 244:707, 1989
20. Bentz M, Werner CA, Döhner H, Joos S, Barth TFE, Siebert R, Schröder M, Stilgenbauer S, Fischer K, Möller P, Lichter P: High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 88:1437, 1996
21. Welch PJ, Wang JYJ: A C-terminal protein-binding domain in the retmoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779, 1993
22. Hasseijian RP, Aster JC, Davi F, Weinberg DS, Sklar J: Modulated expression of notch 1 during thymocyte development. Blood 88:970, 1996
23. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79:551, 1994
24. Kitahara K, Yasni W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, Hisatsugu T, Tahara E: Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 62:25, 1995
25. Walterhouse D, Ahmed M, Slusarski D, Kalamaras J, Boucher D, Holmgren R, lannaccone P: gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. Dev Dyn 196:91, 1993
26. Fischer U, Meltzer P, Meese E: Twelve amplified and expressed genes localized in a single domain in glioma. Hum Genet 98:625, 1996
27. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT: Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535, 1993
28. Jankowski SA, Mitchell DS, Smith SH, Trent JM, Meltzer PS: SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 9:1205, 1994
29. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP: Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299, 1994
30. Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O: Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosom Cancer 17:254, 1996
31. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237, 1992
32. Rolling C, Treton D, Beckmann P, Galanaud P, Richard Y: JAK3 associates with the human interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering. Oncogene 10:1757, 1995
33. Amakawa R, Fukuhara S, Ohno H, Tanabe S, Horii M, Matsuyama F, Kato I, Kakita T, Naguchi O: Amplified and rearranged bcl-2 gene in two lymphoma cell lines, FL-218 and FL-318, carrying a 14;18 translocation. Cancer Res 50:2423, 1990
34. Aggarwal BB, Pocsik E, Totpal K, Ali-Osman F: Suppression of antiproliferative effects of tumor necrosis factor by transfection of cells with human platelet-derived growth factor B/c-sis gene. FEBS Lett 357:1, 1995
35. Tanaka T, Takahashi K, Miyachi Y, Imamura S: Chromosomal translocation t(1;22) and sis oncogene variant with gene amplification in a case of atypical malignant lymphoma. Cancer Invest 8:613, 1990
36. Gascoyne RD, Adomat SA, Krajewsa S, Krajewski M, Horsman DE, Tolcher AW, O'Reilly SE, Hoskins P, Coldman AJ, Reed JC, Connors JM: Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90:244, 1997
37. Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ: Alterations at the rel locus in human lymphoma. Oncogene 6:1235, 1991
38. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RSK, Dalla-Favera R: B-cell lymphoma-associaied chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-KB p50. Cell 67:1075, 1991
39. Haluska FG, Tsujimoto Y, Croce CM: Oncogene activation by chromosome translocation in human malignancy. Annu Rev Genet 21:321, 1987
40. Joos S, Otanos-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P, Lichter P: Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87:1571, 1996
41. Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knutila S: BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 90:1168, 1997
42. Dierlamm J, Rosenberg C, Stul M, Pittaluga S, Wlodwska I, Michaux L, Dehaen M, Verhoel G, Thomas J, de Kelver W, Bakker-Schut T, Cassiman JJ, Raap AK, De Wolf-Peters C, Van den Berghe H, Hagemeijer A: Characteristic pattern of chromosomal gains and losses in marginal zone B-cell lymphoma detected by comparative genomic hybridization. Leukemia 11:747, 1997
43. Gauwerky CE, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM: Evolution of B-cell malignancy: Pre B-cell leukemia resulting from myc activation in a B-cell neoplasm with a rearranged bcl-2 gene. Proc Natl Acad Sci USA 85:8548, 1988
44. de Jong D, Voetdijk BMH, Beverstock GC, van Ommen GJB, Willemze R, Kluin PM: Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma, N Engl J Med 318:1373, 1988
45. Yano T, Jaffe ES, Longo DL, Raffeid M: Myc rearrangements in histologically progressed follicular lymphomas. Blood 80:758, 1992
46. Dalla-Favera R, Ye BH, LoCoco F, Chang C-C, Cechova K, Zhang J, Migliazza A, Mellado W, Niu H, Chaganti S, Chen W, Rao PH, Parsa NZ, Louie DC, Offit K, Chaganti RSK: BCL-6 and the molecular pathogenesis of B cell lymphoma. Cold Spring Harb Syrhp Quant Biol 59:117, 1994